Ketamine has been introduced into clinical practice for nearly 46 years, with the objective to act as an anesthetic substance with analgesia, amnesia, unconsciousness, and immobility properties. Ketamine has been found to interact with a number of recep-tors such as opioids, muscarinic and N-methyl-D-aspartate receptors (NMDAr)
Ketamine has been introduced into clinical practice for nearly 46 years, with the objective to act as an anesthetic substance with analgesia, amnesia, unconsciousness, and immobility properties. Ketamine has been found to interact with a number of recep-tors such as opioids, muscarinic and N-methyl-D-aspartate receptors (NMDAr)